Inovelon rufinamide regulatory update

Eisai submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW)

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE